Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Red blood cell-coupled tissue plasminogen activator prevents impairment of cerebral vasodilatory responses through inhibition of c-Jun-N-terminal kinase and potentiation of p38 mitogen-activated protein kinase after cerebral photothrombosis in the newborn pig.
|
21037505 |
2011 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
|
20123226 |
2010 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
[Thrombolysis in acute ischemic stroke in basic hospitals. four cases reports].
|
20488584 |
2010 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
|
20536612 |
2010 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
|
17903870 |
2007 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
The Interventional Management of Stroke (IMS) II Study.
|
17525387 |
2007 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
|
16809570 |
2006 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
[Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].
|
17086147 |
2006 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
|
16126134 |
2005 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
|
14986460 |
2004 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
|
15087567 |
2004 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
|
15017018 |
2004 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Predicting outcome in ischemic stroke: external validation of predictive risk models.
|
12511774 |
2003 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
|
11940547 |
2002 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
|
12221155 |
2002 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
11108748 |
2000 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong?
|
10572812 |
1999 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.
|
9566367 |
1998 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke.
|
9633741 |
1998 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
9259745 |
1997 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
|
9400355 |
1997 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Nursing management of acute complications following rt-PA in acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
|
9479658 |
1997 |
Cerebral Ischemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Tissue plasminogen activator for acute ischemic stroke.
|
7477192 |
1995 |